RECENT NEWS

Medovate will be joining the Association of British HealthTech Industries (ABHI) US Accelerator 2022 cohort.

A quick and cheap blood test could help doctors to spot people at high risk of death following a suspected heart attack, according to research funded by the British Heart Foundation.

A new report, from the Health Foundation, calls for the Government to take stronger action to tackle the leading risk factors for ill health, following years of "slow, uneven and disjointed policy making".

A new Maternity Disparities Taskforce will tackle disparities in maternity care experienced by women from ethnic minority groups and those living in deprived areas.

Results of a clinical study published in the British Medical Journal demonstrate that IBEX Trueview software can accurately predict fracture risk from standard DR scans – paving the way for advances in osteoporosis detection.

New guidelines have been published to increase the safety of regional anaesthesia.

For patients with rheumatic arthritis and other chronic inflammatory diseases, discontinuing biologic disease-modifying anti-rheumatic drugs (bDMARDs) prior to orthopaedic surgery does not appear to increase the risk of surgical site infections.

Rapidly growing waiting times for health services on top of the disproportionate burden on their mental health, wrought by the pandemic, risks leaving a generation of children and young people behind.

The RCP and the Getting It Right First Time programme (GIRFT) have published a statement which sets out how best to support patients who present with emergency and urgent medical care needs.

The Department of Health and Social Care (DHSC), with the support of the NHS, has launched a major new national campaign to increase the number of those eligible attending their cervical screening in England.

Patients will receive better, more joined-up care under new plans announced to improve the links between health and social care.

Medovate has announced that it has entered into an agreement with Mercury Medical for exclusive distribution of the FDA-cleared device SAFIRA (SAFer Injection for Regional Anesthesia) across the whole of the US.

Biases in artificial intelligence will aim to be eradicated in a world first as the NHS in England trials a new approach to the ethical adoption of AI in healthcare.

Patients waiting for major procedures will be given extensive support from dedicated NHS care teams to make sure they are fighting fit for surgery.

Thousands of patients are set to benefit from pioneering new technology being backed by the NHS that aims to revolutionise cancer testing techniques across the country.

An innovative new drug for treating advanced or recurrent endometrial cancer in adults who have had platinum-based chemotherapy is being recommended by NICE as an option for use within the Cancer Drugs Fund.

HCA Healthcare UK has opened the doors to its latest investment in complex cancer care; a £26milion specialist complex haematology and oncology unit at HCA Healthcare UK at University College Hospital.

Patients waiting for elective surgeries will benefit from increased transparency and information sharing following the launch of the new NHS ‘My Planned Care’ platform.

Health and Social Care Secretary Sajid Javid has declared "a war on cancer” and launched a call for evidence to underpin an ambitious 10-Year Cancer Plan for England.

Researchers have found that the introduction of a bundle of evidence-based practices reduced death or severe brain bleeding from 27.4% to 15% in premature babies.